Analysis of Tabio Corporation (2668)
Tabio Corporation (symbol: 2668) has been showing some fluctuations in its stock price recently. The Relative Strength Index (RSI) indicator has been hovering around 50, indicating a neutral stance in the market. The Moving Average Convergence Divergence (MACD) indicator has been showing some positive momentum with the MACD histogram moving into positive territory.
The stock price has been trading around 1200-1208 range, with some volatility in the past few days. The Simple Moving Average (SMA) and Exponential Moving Average (EMA) are both above the current price, indicating a bullish trend.
Overall, Tabio Corporation seems to be in a consolidation phase with some bullish momentum building up. Traders and investors may want to keep an eye on further price movements and key support/resistance levels for potential trading opportunities.
Income statement 💸
Here are the revenue figures for the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general increasing trend in sales over the years.
- The highest sales figure was recorded in FY 2022.
These trends can provide insights into the company's performance and market conditions over the specified fiscal years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has been trading within a range over the past 52 weeks.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the stock being valued at a premium based on price to book and price to sales ratios. The market capitalization and enterprise value are substantial.
The stock price summary indicates the stock's performance over the past 50 and 200 days, as well as its 52-week low and high prices.
Lastly, the dividends and splits information shows the company's dividend history, payout ratio, and upcoming dividend dates. The company has a history of dividend payments and has undergone a stock split in the past.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2021.
5. Financing activities show significant cash outflows, mainly due to common stock repurchases and dividend payments.
6. Investing activities also show significant cash flows related to acquisitions, investments, and capital expenditures.
7. Overall, the company seems to be managing its cash flows effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, compared to $6.13 a year ago.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 a year ago.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and the next fiscal years compared to the previous periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.MACD of 2668